270 related articles for article (PubMed ID: 26471264)
1. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.
Kalaitzakis E; Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kontodimopoulos N
Qual Life Res; 2016 Apr; 25(4):947-57. PubMed ID: 26471264
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV).
Stepanova M; Younossi I; Racila A; Younossi ZM
Value Health; 2018 May; 21(5):612-621. PubMed ID: 29753360
[TBL] [Abstract][Full Text] [Related]
3. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
[TBL] [Abstract][Full Text] [Related]
4. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
Richardson SS; Berven S
Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
[TBL] [Abstract][Full Text] [Related]
5. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
Lamu AN; Olsen JA
Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314
[TBL] [Abstract][Full Text] [Related]
6. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
7. Mapping the Gastrointestinal Quality of Life Index to short-form 6D utility scores.
Lee L; Kaneva P; Latimer E; Feldman LS
J Surg Res; 2014 Jan; 186(1):135-41. PubMed ID: 24021906
[TBL] [Abstract][Full Text] [Related]
8. Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D.
Teckle P; McTaggart-Cowan H; Van der Hoek K; Chia S; Melosky B; Gelmon K; Peacock S
Health Qual Life Outcomes; 2013 Dec; 11():203. PubMed ID: 24289488
[TBL] [Abstract][Full Text] [Related]
9. Mapping the neck disability index to SF-6D in patients with chronic neck pain.
Zheng Y; Tang K; Ye L; Ai Z; Wu B
Health Qual Life Outcomes; 2016 Feb; 14():21. PubMed ID: 26879341
[TBL] [Abstract][Full Text] [Related]
10. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
Wong CK; Lam CL; Wan YF; Rowen D
Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
[TBL] [Abstract][Full Text] [Related]
11. Mapping the disease-specific LupusQoL to the SF-6D.
Meacock R; Harrison M; McElhone K; Abbott J; Haque S; Bruce I; Teh LS
Qual Life Res; 2015 Jul; 24(7):1749-58. PubMed ID: 25510215
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and quality of life: Comparing results from utility instruments and Diabetes-39.
Chen G; Iezzi A; McKie J; Khan MA; Richardson J
Diabetes Res Clin Pract; 2015 Aug; 109(2):326-33. PubMed ID: 26013567
[TBL] [Abstract][Full Text] [Related]
13. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.
Dan AA; Kallman JB; Srivastava R; Younoszai Z; Kim A; Younossi ZM
Liver Transpl; 2008 Mar; 14(3):321-6. PubMed ID: 18306356
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC.
Younossi ZM; Stepanova M; Younossi I; Racila A
Hepatol Commun; 2023 Feb; 7(2):e0049. PubMed ID: 36724122
[TBL] [Abstract][Full Text] [Related]
15. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
[TBL] [Abstract][Full Text] [Related]
16. Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country.
Yousefi M; Nahvijou A; Sari AA; Ameri H
Value Health Reg Issues; 2021 May; 24():57-66. PubMed ID: 33508752
[TBL] [Abstract][Full Text] [Related]
17. Factors that reduce health-related quality of life in patients with primary sclerosing cholangitis.
Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kalaitzakis E
Clin Gastroenterol Hepatol; 2012 Jul; 10(7):769-775.e2. PubMed ID: 22343690
[TBL] [Abstract][Full Text] [Related]
18. Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores.
Liu T; Li S; Wang M; Sun Q; Chen G
Patient; 2020 Oct; 13(5):537-555. PubMed ID: 32382953
[TBL] [Abstract][Full Text] [Related]
19. Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study.
Yang Q; Huang D; Jiang L; Tang Y; Zeng D
Front Endocrinol (Lausanne); 2023; 14():1160882. PubMed ID: 37664851
[TBL] [Abstract][Full Text] [Related]
20. Use of Bayesian methods to model the SF-6D health state preference based data.
Kharroubi SA
Health Qual Life Outcomes; 2018 Dec; 16(1):234. PubMed ID: 30563528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
